Market Value129,351,000
Total Holdings52
File Date2016-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
ONCE / Spark Therapeutics, Inc.
ALKS / Alkermes plc
QGEN / Qiagen N.V.
XNCR / Xencor, Inc.
EPZM / Epizyme Inc
BIIB / Biogen Inc.
REGN / Regeneron Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc.
76028H209 / Repros Therapeutics, Inc. Call
AGIO / Agios Pharmaceuticals, Inc.
AMGN / Amgen Inc.
IONS / Ionis Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc.
AVDL / Avadel Pharmaceuticals plc
KPTI / Karyopharm Therapeutics Inc.
ELDN / Eledon Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation
ISEE / IVERIC bio Inc
MCRB / Seres Therapeutics, Inc.
MRK / Merck & Co., Inc.
MACK / Merrimack Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
PSDV / pSivida Corp.
CELG / Celgene Corp.
VRTX / Vertex Pharmaceuticals Incorporated
ADMS / Adamas Pharmaceuticals Inc
ZGNX / Zogenix Inc
US00448Q2012 / Achillion Pharmaceuticals, Inc.
DRNA / Dicerna Pharmaceuticals Inc
KALV / KalVista Pharmaceuticals, Inc.
PLXP / PLx Pharma Inc.
FLDM / Standard BioTools Inc
IWM / iShares Trust - iShares Russell 2000 ETF Put
SGEN / Seagen Inc
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
CLVS / Clovis Oncology Inc
BMY / Bristol-Myers Squibb Company
MDCO / Medicines Company
SNR / New Senior Investment Group Inc
NSTG / NanoString Technologies, Inc.
PFE / Pfizer Inc.
SDS / ProShares Trust - ProShares UltraShort S&P500
ILMN / Illumina, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
PRTK / Paratek Pharmaceuticals Inc.
MTD / Mettler-Toledo International Inc.
NKTR / Nektar Therapeutics
LOXO / Loxo Oncology, Inc.
451731103 / Ignyta, Inc.
MDVN / Medivation, Inc.
VCEL / Vericel Corporation
SRRA / Sierra Oncology Inc
HOLX / Hologic, Inc.
INCY / Incyte Corporation
SIOX / Sio Gene Therapies Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
INFI / Infinity Pharmaceuticals Inc.
MGNX / MacroGenics, Inc.
NVAX / Novavax, Inc. Put
IBB / iShares Trust - iShares Biotechnology ETF
NVAX / Novavax, Inc. Call